Kenneth Allen Myszkowski - 04 Jan 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Chief Financial Officer
Signature
/s/Kenneth Myszkowski
Issuer symbol
ARWR
Transactions as of
04 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 18:14:59 UTC
Previous filing
30 Dec 2022
Next filing
29 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $0 +60,000 +18% $0.000000 396,704 04 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments, with a commencement date of 1/4/23.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.